Korea Union Pharmaceutical (080720) has 0 disclosed insider purchases and 0 disclosed disposals on record, filed by 0 distinct insiders. The earliest filing StockDrifts holds for Korea Union Pharmaceutical is dated 2024-08-14; the most recent is 2026-05-28. All of it is parsed from DART D001/D002 insider disclosures, the official disclosure system operated by the Financial Supervisory Service (Korea).
| Date | Type | Source | Insider | Position | Shares | Price at filing | Return | Value |
|---|---|---|---|---|---|---|---|---|
| 2026-05-28 | BUY | 제3자배정유상증자 | 부광약품 Bukwang Pharmaceutical | - | 60.0M | ₩2,725 | +0.0% | ₩163.5B ($113.5M) |
| 2026-05-19 | BUY | 기타 | 박광석 Park Gwang-seok | - | 9.5M | ₩2,725 | +0.0% | ₩25.8B ($17.9M) |
| 2025-06-23 | BUY | 기타 | 멜빈에프앤비 Melvin F&B | - | 1.6M | ₩2,725 | +0.0% | ₩4.3B ($3.0M) |
| 2025-06-23 | SELL | 기타 | 백병하 Baek Byeong-ha | CEO | -720.6K | ₩2,725 | +0.0% | ₩2.0B ($1.4M) |
| 2025-06-23 | SELL | 기타 | 안희숙 Ahn Hee-sook | - | -856.0K | ₩2,725 | +0.0% | ₩2.3B ($1.6M) |
| 2024-12-09 | BUY | 장외매수 | 양태현 Taehyun Yang | Internal director | 3.1K | ₩2,725 | +0.0% | ₩9M ($6K) |
| 2024-11-06 | BUY | 증여취소 | 안희숙 Ahn Hee-sook | - | 285.2K | ₩2,725 | +0.0% | ₩777M ($540K) |
| 2024-11-06 | BUY | 증여취소 | 백병하 Baek Byeong-ha | CEO | 720.6K | ₩2,725 | +0.0% | ₩2.0B ($1.4M) |
| 2024-08-14 | SELL | 증여 | 백병하 Baek Byeong-ha | CEO | -720.6K | ₩6,060 | +55.0% | ₩4.4B ($3.0M) |
| 2024-08-14 | SELL | 증여 | 안희숙 Ahn Hee-sook | - | -285.2K | ₩6,060 | +55.0% | ₩1.7B ($1.2M) |
Every trade listed above is disclosed in DART D001/D002 insider disclosures, filed with the Financial Supervisory Service (Korea). View the original DART filings for Korea Union Pharmaceutical. For how StockDrifts scores these disclosures, see the Korea insider signal tier research, or browse every Korean stock we track.